BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4916020)

  • 21. [Estrogen treatment of prostatic cancer after total prostatectomy: rates of survival and cardiovascular complications in the Mellinger-Belt series].
    Belt E; Schröder FH
    Urologe; 1971 Mar; 10(2):56-8. PubMed ID: 5577978
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hormone therapy of cancer of the prostate gland].
    Madsen PO; Pedersen IF; Knut OE
    Urol Nefrol (Mosk); 1970; 35(3):25-8. PubMed ID: 4915239
    [No Abstract]   [Full Text] [Related]  

  • 23. Editorial: Stilboestrol for prostatic cancer.
    Br Med J; 1974 Jun; 2(5918):520. PubMed ID: 4407126
    [No Abstract]   [Full Text] [Related]  

  • 24. Orchiectomy for advanced prostatic carcinoma. A reevaluation.
    Blackard CE; Byar DP; Jordan WP
    Urology; 1973 Jun; 1(6):553-60. PubMed ID: 4588820
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostatic carcinoma: reflections on its natural history, diagnosis, and therapy.
    Schirmer HK
    J Surg Oncol; 1969; 1(2):131-40. PubMed ID: 5406361
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group.
    Surg Gynecol Obstet; 1967 May; 124(5):1011-7. PubMed ID: 6022476
    [No Abstract]   [Full Text] [Related]  

  • 27. Regression of prostatic cancer metastasis by high doses of diethylstilbestrol diphosphate.
    Susan LP; Roth RB; Adkins WC
    Urology; 1976 Jun; 7(6):598-601. PubMed ID: 936380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of pretreatment serum nonprotein-bound cortisol and total 17-hydroxycorticosteroid values with survival in patients with prostatic cancer.
    Blackard CE; Byar DP; Seal US; Doe RP
    N Engl J Med; 1974 Oct; 291(15):751-5. PubMed ID: 4369891
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hormone treatment in the prostatic cancer].
    Madsen PO; Pedersen JF; Knuth OE
    Urologe; 1969; 8(6):330-3. PubMed ID: 5405377
    [No Abstract]   [Full Text] [Related]  

  • 30. Cancer of the prostate.
    N Engl J Med; 1968 Apr; 278(15):848-9. PubMed ID: 5642506
    [No Abstract]   [Full Text] [Related]  

  • 31. Hormone therapy for prostate cancer: results of the Veterans Administration Cooperative Urological Research Group studies.
    Byar DP; Corle DK
    NCI Monogr; 1988; (7):165-70. PubMed ID: 3050535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial: Stilboestrol: use and abuse in prostatic disease.
    N Z Med J; 1974 Aug; 80(521):113. PubMed ID: 4529401
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of prostatic carcinoma with polyestradiol phosphate combined with ethinylestradiol.
    Jönsson G
    Scand J Urol Nephrol; 1971; 5(2):97-102. PubMed ID: 5093112
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recurrence of cancer of the prostate after initial treatment with diethylstilbestrol (DES) in a homogeneous series of 175 cases].
    Reziciner S
    Ann Urol (Paris); 1997; 31(4):213-24. PubMed ID: 9412346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival of patients with incidentally found microscopic cancer of the prostate: results of a clinical trial of conservative treatment.
    Byar DP
    J Urol; 1972 Dec; 108(6):908-13. PubMed ID: 5082745
    [No Abstract]   [Full Text] [Related]  

  • 36. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
    Chang A; Yeap B; Davis T; Blum R; Hahn R; Khanna O; Fisher H; Rosenthal J; Witte R; Schinella R; Trump D
    J Clin Oncol; 1996 Aug; 14(8):2250-7. PubMed ID: 8708714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular complications in the treatment of prostatic carcinoma.
    Glashan RW; Robinson MR
    Br J Urol; 1981 Dec; 53(6):624-7. PubMed ID: 7317753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effective therapy of the hot flashes during hormone withdrawal treatment in patients with advanced prostatic carcinoma].
    Kliesch S; Behre HM; Roth S
    Dtsch Med Wochenschr; 1997 Jul; 122(30):940-5. PubMed ID: 9280708
    [No Abstract]   [Full Text] [Related]  

  • 39. [Initial experience with ethinyl estradiol sulfonate (J 96) in the therapy of prostate carcinoma].
    Guddat HM; Schnorr D; Dörner G; Stahl F; Rohde W
    Z Urol Nephrol; 1979 Mar; 72(3):153-7. PubMed ID: 380227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of advanced carcinoma of the prostate.
    Blackard CE
    Surg Gynecol Obstet; 1971 Jul; 133(1):97-8. PubMed ID: 5091832
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.